ArticleCureus2025
When Acute Epstein-Barr Virus Mimics HIV: A Case of False-Positive p24 Antigen and Low-Level HIV Antibody Reactivity.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
False-positive HIV screening results are uncommon but clinically significant, often leading to patient anxiety and diagnostic uncertainty. Acute Epstein-Barr virus (EBV) infection is a recognised but rare cause of cross-reactivity with fourth-generation HIV assays, particularly p24 antigen and low-level HIV antibody reactivity. We report a 57-year-old male with a history of hypothyroidism and atrial fibrillation who presented with sore throat, tender cervical and occipital lymphadenopathy, diffuse rash, dark urine, and fatigue. Initial investigations showed lymphocytosis and marked transaminitis. Fourth-generation HIV testing was repeatedly reactive, with positive p24 antigen and low-level HIV-1/2 antibody reactivity across three separate samples. In contrast, HIV-1 RNA and HIV-2 RNA viral loads were consistently undetectable (<20 copies/mL). EBV serology demonstrated viral capsid antigen (VCA) IgM positivity with transient EBV DNA detection, and the clinical presentation was consistent with acute EBV infection. Additional viral serologies, including cytomegalovirus (CMV), varicella-zoster virus (VZV), measles, parvovirus, and syphilis, were negative. Monkeypox PCR was weakly positive once but negative on repeat testing. The patient's wife, who was pregnant, tested negative for HIV. He improved with supportive care, and follow-up demonstrated normalisation of liver function tests and persistently negative HIV serology, confirming a false-positive HIV result in the setting of acute EBV infection. This case is significant because it illustrates a rare but important diagnostic pitfall: acute EBV infection mimicking acute HIV. The implications of a false HIV diagnosis are profound, carrying psychological, social, and clinical consequences, heightened in this case by the patient's pregnant wife. The discrepancy between reactive screening assays and undetectable HIV-1 and HIV-2 RNA underscores the importance of confirmatory testing and clinical correlation. Clinicians should be aware that acute EBV infection may result in false-positive HIV p24 antigen and antibody reactivity. Reporting such cases adds to the limited literature and serves as an important reminder to interpret discordant HIV results with caution to avoid misdiagnosis and unnecessary psychological burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.